Young Mother with Lynch Syndrome Doing Well on Immunotherapy | Dana-Farber Cancer Institute
Shortly after Stephanie Dobson’s rectal cancer diagnosis, she and her husband met with Dana-Farber’s Matthew Yurgelun, MD, who already had a plan.
Shortly after Stephanie Dobson’s rectal cancer diagnosis, she and her husband met with Dana-Farber’s Matthew Yurgelun, MD, who already had a plan.
Studies have suggested that 0.002% to 0.03% of NIPT results may indicate a possible maternal cancer. Among patients with malignancy-suspicious NIPT results, 6.4% to 73.0%…
This cohort study uses registry data to examine the risk of colorectal cancer (CRC) and CRC-specific death for up to 20 years after having a…
Melanoma of the Skin statistics
The first patient has been dosed in the phase 2 AlphaBreak trial with FPI-2265 for the treatment of metastatic castration-resistant prostate cancer, marking a significant…
Outcome improvements with lutetium Lu 177 vipivotide tetraxetan vs ARPI change favored prior treatment with abiraterone vs enzalutamide in mCRPC.
James Cribbin and his wife, Alexandra, came to MD Anderson for its expertise in marginal zone lymphoma, a rare subtype of non-Hodgkin lymphoma. What they…
Healio is accepting submissions for its third annual peer-recognition program, Healio Honors. The goal of the program is to celebrate health care professionals who go…
Valentin Ortiz-Maldonado, MD, Hospital Clinic Barcelona, Barcelona, Spain, discusses strategies for preventing relapse in patients with B-cell acute lymphoblastic leukemia (B-ALL) in both the pre…
TAR-200 displayed a high complete response rate in Bacillus Calmette–Guérin-unresponsive high-risk non–muscle-invasive bladder cancer.
Wolters Kluwer (“we” or “us”) wants to inform you about the ways we process your personal information. In this Privacy & Cookie Notice we explain…